ArticleJournal of the American Heart Association2017

Impaired Fasting Glucose Is the Major Determinant of the 20-Year Mortality Risk Associated With Metabolic Syndrome in Nondiabetic Patients With Stable Coronary Artery Disease.

Arwa Younis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.